Access the full text.
Sign up today, get DeepDyve free for 14 days.
Paola Patrignani, P. Filabozzi, Carlo Patrono (1982)
Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects.The Journal of clinical investigation, 69 6
T. Fawcett, Q. Xu, N. Holbrook (1997)
Potentiation of heat stress-induced hsp70 expression in vivo by aspirin.Cell stress & chaperones, 2 2
M. Cattaneo (2007)
Laboratory detection of 'aspirin resistance': what test should we use (if any)?European heart journal, 28 14
S. Schwartz, D. Deblois, E. O’Brien (1995)
The intima. Soil for atherosclerosis and restenosis.Circulation research, 77 3
R. Benamouzig, J. Deyra, Antoine Martin, Bernard Girard, E. Jullian, B. Piednoir, D. Couturier, T. Coste, J. Little, S. Chaussade (2003)
Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial.Gastroenterology, 125 2
T. Kuwano, S. Nakao, Hidetaka Yamamoto, M. Tsuneyoshi, Tomoya Yamamoto, M. Kuwano, M. Ono (2004)
Cyclooxygenase 2 is a key enzyme for inflammatory cytokine‐induced angiogenesisThe FASEB Journal, 18
J. Clària, M. Lee, C. Serhan (1996)
Aspirin-Triggered Lipoxins (15-epi-LX) Are Generated by the Human Lung Adenocarcinoma Cell Line (A549)–Neutrophil Interactions and Are Potent Inhibitors of Cell ProliferationMolecular Medicine, 2
N. Murashige, M. Kami, Masayuki Ikeda (2007)
Aspirin, COX-2, and the risk of colorectal cancer.The New England journal of medicine, 357 8
N. Grosser, A. Abate, S. Oberle, H. Vreman, P. Dennery, J. Becker, T. Pohle, D. Seidman, H. Schröder (2003)
Heme oxygenase-1 induction may explain the antioxidant profile of aspirin.Biochemical and biophysical research communications, 308 4
A. Sakai, N. Kume, E. Nishi, K. Tanoue, M. Miyasaka, T. Kita (1997)
P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes.Arteriosclerosis, thrombosis, and vascular biology, 17 2
B. Farrell, J. Godwin, S. Richards, C. Warlow (1991)
The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.Journal of Neurology, Neurosurgery & Psychiatry, 54
R. Poston, D. Haskard, J. Coucher, N. Gall, R. Johnson-Tidey (1992)
Expression of intercellular adhesion molecule-1 in atherosclerotic plaques.The American journal of pathology, 140 3
M. Paul-Clark, Thong Cao, N. Moradi-Bidhendi, D. Cooper, D. Gilroy (2004)
15-epi-lipoxin A4–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute InflammationThe Journal of Experimental Medicine, 200
Kevin Montgomery, Laurelee OSBORNt, Catherine HESSIONt, Richard, TIZARDt, Deborah GOFFt, Cornelia VASSALLOt, I. Phillip, Tarro, Karol Bomsztyk, RoY LOBBt, John Harlan, T. Pohlman (1991)
Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription.Proceedings of the National Academy of Sciences of the United States of America, 88
The Group (1991)
Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic eventsThe Lancet, 338
K. Gronert, Titti Martinsson-Niskanen, S. Ravasi, Chia Nan, C. Serhan (2001)
Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.The American journal of pathology, 158 1
G. FitzGerald, J. Oates, J. Hawiger, R. Maas, L. Jackson, Roberts Ii, J. Lawson, A. Brash (1983)
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.The Journal of clinical investigation, 71 3
J. Pierce, M. Read, H. Ding, F. Luscinskas, T. Collins (1996)
Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration.Journal of immunology, 156 10
C. Baigent, R. Collins, P. Appleby, S. Parish, P. Sleight, R. Peto (1998)
ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neitherBMJ, 316
M. Oshima, J. Dinchuk, S. Kargman, H. Oshima, Bruno Hancock, E. Kwong, J. Trzăskos, Jilly Evans, M. Taketo (1996)
Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)Cell, 87
Williams Kj, I. Tabas (1999)
Atherosclerosis--an inflammatory disease.The New England journal of medicine, 340 24
J. Topper, Jiexing Cai, D. Falb, M. Gimbrone (1996)
Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress.Proceedings of the National Academy of Sciences of the United States of America, 93 19
Takamori Yotsui, O. Yasuda, H. Kawamoto, M. Higuchi, Yukana Chihara, E. Umemoto, Toshiyuki Tanaka, M. Miyasaka, H. Rakugi, T. Ogihara (2007)
Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cellsFEBS Letters, 581
G. Hansson, J. Holm, L. Jonasson (1989)
Detection of activated T lymphocytes in the human atherosclerotic plaque.The American journal of pathology, 135 1
M. Sonoshita, K. Takaku, N. Sasaki, Y. Sugimoto, F. Ushikubi, S. Narumiya, M. Oshima, M. Taketo (2001)
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout miceNature Medicine, 7
D. Taubert, R. Berkels, N. Grosser, H. Schröder, D. Gründemann, E. Schömig (2004)
Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of actionBritish Journal of Pharmacology, 143
Vincent Yang, J. Shields, Stanley Hamilton, Ernst Spannhake, Walter Hubbard, L. Hylind, C. Robinson, F. Giardiello (1998)
Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis.Cancer research, 58 8
B. McMahon, Catherine Stenson, Fiona McPhillips, Aine Fanning, Hugh Brady, Catherine Godson (2000)
Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors.The Journal of biological chemistry, 275 36
Stefano Fiore, Jane Maddox, H. Perez, Charles Serhan (1994)
Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptorThe Journal of Experimental Medicine, 180
(2002)
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ : British Medical Journal, 324
V. Nascimento-Silva, M. Arruda, C. Barja-Fidalgo, I. Fierro (2006)
Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: A novel antioxidative mechanismThrombosis and Haemostasis, 97
Xiao Xu, L. Sansores-García, X. Chen, N. Matijevic-Aleksic, M. Du, K. Wu, K. Wu (1999)
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate.Proceedings of the National Academy of Sciences of the United States of America, 96 9
K. O’Brien, T. McDonald, A. Chait, M. Allen, C. Alpers (1996)
Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content.Circulation, 93 4
E. Kopp, S. Ghosh (1994)
Inhibition of NF-kappa B by sodium salicylate and aspirin.Science, 265 5174
R. Breyer, C. Kennedy, Yahua Zhang, M. Breyer (2000)
Structure‐Function Analyses of Eicosanoid Receptors: Physiologic and Therapeutic ImplicationsAnnals of the New York Academy of Sciences, 905
R. Gerli, P. Gresele, O. Bistoni, C. Paolucci, L. Lanfrancone, S. Fiorucci, C. Muscat, V. Costantini (2001)
Salicylates Inhibit T Cell Adhesion on Endothelium Under Nonstatic Conditions: Induction of L-Selectin Shedding by a Tyrosine Kinase-Dependent MechanismThe Journal of Immunology, 166
C. Forbes (1997)
EUROPEAN STROKE PREVENTION STUDY 2: DIPYRIDAMOLE AND ACETYLSALICYLIC ACID IN THE SECONDARY PREVENTION OF STROKEInternational Journal of Clinical Practice, 51
N. Grosser, H. Schröder (2003)
Aspirin Protects Endothelial Cells From Oxidant Damage Via the Nitric Oxide-cGMP PathwayArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 23
T. Takano, S. Fiore, J. Maddox, H. Brady, N. Petasis, C. Serhan (1997)
Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory ReceptorsThe Journal of Experimental Medicine, 185
C. Weber, W. Erl, A. Pietsch, P. Weber (1995)
Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells.Circulation, 91 7
B. Rocca, P. Secchiero, G. Ciabattoni, F. Ranelletti, L. Catani, L. Guidotti, E. Melloni, N. Maggiano, G. Zauli, C. Patrono (2002)
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed plateletsProceedings of the National Academy of Sciences of the United States of America, 99
C. Serhan, Chia Nan (2002)
Lipid-Derived Mediators in Endogenous Anti-Inflammation and Resolution: Lipoxins and Aspirin-Triggered 15-epi-LipoxinsThe Scientific World Journal, 2
J. Davignon, P. Ganz (2004)
Role of Endothelial Dysfunction in AtherosclerosisCirculation: Journal of the American Heart Association, 109
W. Smith, D. Dewitt, R. Garavito (2000)
Cyclooxygenases: structural, cellular, and molecular biology.Annual review of biochemistry, 69
Jonathan Miner, Adam Hoffhines (2007)
The discovery of aspirin's antithrombotic effects.Texas Heart Institute journal, 34 2
P. Ridker, M. Cushman, M. Stampfer, R. Tracy, C. Hennekens (1997)
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.The New England journal of medicine, 336 14
M. Halushka, Linda Walker, P. Halushka (2003)
Genetic variation in cyclooxygenase 1: Effects on response to aspirinClinical Pharmacology & Therapeutics, 73
M. Hovens, J. Snoep, J. Eikenboom, J. Bom, B. Mertens, M. Huisman (2007)
Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review.American heart journal, 153 2
J. Baron, B. Cole, R. Sandler, R. Haile, D. Ahnen, R. Bresalier, G. McKeown-Eyssen, R. Summers, R. Rothstein, C. Burke, D. Snover, T. Church, John Allen, M. Beach, G. Beck, J. Bond, T. Byers, E. Greenberg, J. Mandel, N. Marcon, L. Mott, L. Pearson, F. Saibil, R. Stolk (2003)
A randomized trial of aspirin to prevent colorectal adenomas.The New England journal of medicine, 348 10
(2005)
Atherothrombosis and high - risk plaque . I . Evolving concepts
Aspirin exerts anti-thrombotic action by acetylating and inactivating cyclooxygenase-1, preventing the production of thromboxane A 2 in platelets. Through this inhibition of platelet function, aspirin is considered as a preventative of ischemic diseases such as coronary and cerebral infarction. However, many studies have revealed that aspirin has other beneficial actions in addition to its anti-platelet activity. For example, aspirin may confer some benefit against colorectal cancer. Here, we discuss the involvement of inflammation in atherosclerosis and how aspirin exerts its beneficial actions in atherosclerotic diseases and cancer.
Cellular and Molecular Life Sciences – Springer Journals
Published: Nov 26, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.